Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Description:** 2-Oxy–4-Hydroxy–5–(2-Hydrazinopyridine)Phenylalanine is a synthetic small molecule and an experimental amino acid derivative. It is structurally related to phenylalanine, with modifications including a hydrazinopyridine moiety and additional hydroxy/oxy groups on the aromatic ring. The compound has been studied primarily as a mechanistic probe or inhibitor in biochemical research, particularly for its interaction with primary amine oxidase enzymes such as copper-containing amine oxidases. There are no approved therapeutic indications or clinical uses for this compound; it remains an experimental tool in enzymology and structural biology[7][8][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 2-Oxy-4-Hydroxy-5-(2-Hydrazinopyridine)Phenylalanine.